Chicago Center for Urban Life and Culture

Chicago Center For Music Education (ChiME) Provides 10,000 Instruments To Chicago School Children

Thursday, October 14, 2021 - 1:55pm

CHICAGO, Oct. 14, 2021 /PRNewswire/ -- Amid the challenges presented by the current pandemic, the Chicago Center for Music Education (ChiME) recently launched a program to bring music to more than 3,000 students by providing "Chime Time" instruments to each child, free of charge.

Key Points: 
  • CHICAGO, Oct. 14, 2021 /PRNewswire/ -- Amid the challenges presented by the current pandemic, the Chicago Center for Music Education (ChiME) recently launched a program to bring music to more than 3,000 students by providing "Chime Time" instruments to each child, free of charge.
  • Now in its second iteration, the program continues to deliver instruments and music education to school children virtually and in many classrooms throughout Chicago.
  • The Chicago Center for Music Education (ChiME) provides access to evidenced-based therapy and engagement-based music programs that develop critical skills and foster self and social growth.
  • In 1986, ChiME expanded on our goal to make music education available to children in Chicago by establishing partnerships with Chicago Public Schools (CPS).In 2014, our school began doing business as the Chicago Center for Music Education (ChiME).

Abcentra Appoints Entrepreneur and Cardiologist Michael H. Davidson to Board of Directors

Thursday, October 14, 2021 - 10:37am

LOS ANGELES, Oct. 14, 2021 /PRNewswire/ -- Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors.

Key Points: 
  • LOS ANGELES, Oct. 14, 2021 /PRNewswire/ -- Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors.
  • "Millions of patients are at risk of a cardiovascular event because of inflammation, even after maximal lipid lowering," said Dr. Davidson.
  • "This residual inflammatory risk is particularly evident in the psoriasis, rheumatoid arthritis, and lupus populations, where Abcentra is focusing its initial development of orticumab.
  • Dr. Davidson received his BA/MS from Northwestern University and MD from The Ohio State University School of Medicine.